Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM3FS1G)

Drug Name
RT-001 Drug Info
Synonyms RT-001, Revance therapeutics; BoNTA protein (topical gel, hyperhidrosis), Revance
Indication
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Phase 2 [1]
Friedreich's ataxia 8A03.10 Phase 1/2 [2]
Cross-matching ID
PubChem CID
124037379
CAS Number
CAS 1404475-07-5
TTD Drug ID
DM3FS1G

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Bacterial Botulinum toxin A (Bact botA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
XOMA-3AB DMK0AW6 Clostridium infection 1A04 Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Botulinum toxin A (Bact botA) TTB52WU BXA1_CLOBO Modulator [3]

References

1 ClinicalTrials.gov (NCT01124565) Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of Revance Therapeutics.
4 Clinical pipeline report, company report or official report of XOMA.